Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,555 active trials61 approved drugs296 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,964)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 3 | 160 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00738530 | A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | completed | Phase 3 | 649 | Hoffmann-La RocheINDUSTRY | 18 | Jun 23, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy | terminated | Phase 3 | 63 | Christopher Sweeney, MBBSOTHER | 2 | May 26, 2016 | clinicaltrials |
| NCT01356329 | Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients(Lovenox) | suspended | Phase 3 | 150 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT00729287 | Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer(SELEBLAT) | completed | Phase 3 | 276 | KU LeuvenOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | terminated | Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT01978873 | Efficacy Study Evaluating Chemotherapy in Prostate Cancer(SensiCab) | unknown | Phase 3 | 400 | Örebro University, SwedenOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT02762214 | Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY(RoManHy) | unknown | Phase 3 | 154 | Catholic University of the Sacred HeartOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT01755845 | Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients | unknown | Phase 3 | 300 | xie congyingOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT01756170 | Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients | unknown | Phase 3 | 200 | xie congyingOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT01981707 | F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL) | terminated | Phase 2 / Phase 3 | 12 | University Hospital, GrenobleOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT00631371 | Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects(INTORACT) | completed | Phase 3 | 791 | PfizerINDUSTRY | 30 | Apr 27, 2016 | clinicaltrials |
| NCT01875393 | Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer(PCM304) | completed | Phase 3 | 81 | Steba Biotech S.A.OTHER | 3 | Apr 19, 2016 | clinicaltrials |
| NCT00243646 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | terminated | Phase 3 | 6 | Schiffler Cancer CenterOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02728622 | Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane | completed | Phase 3 | 241 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 0 | Apr 5, 2016 | clinicaltrials |
| NCT00024167 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | terminated | Phase 3 | 265 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02703961 | Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer | unknown | Phase 3 | 598 | Air Force Military Medical University, ChinaOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01603420 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | terminated | Phase 2 / Phase 3 | 2 | Proton Collaborative GroupNETWORK | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00062309 | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer | completed | Phase 3 | 307 | Fox Chase Cancer CenterOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01426880 | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer(GeparSixto) | completed | Phase 2 / Phase 3 | 595 | GBG Forschungs GmbHOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT00554229 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases(ENTHUSE M1) | completed | Phase 3 | 896 | AstraZenecaINDUSTRY | 31 | Feb 8, 2016 | clinicaltrials |
| NCT00334282 | Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | completed | Phase 3 | 435 | GlaxoSmithKlineINDUSTRY | 25 | Feb 5, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT01252069 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | completed | Phase 3 | 132 | PregLem SAINDUSTRY | 4 | Jan 13, 2016 | clinicaltrials |
| NCT01642472 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLext2) | completed | Phase 3 | 64 | PregLem SAINDUSTRY | 4 | Jan 8, 2016 | clinicaltrials |
| NCT00006453 | Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 3 | — | AGO Study GroupOTHER | 2 | Dec 23, 2015 | clinicaltrials |
| NCT00006454 | Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | completed | Phase 3 | — | AGO Study GroupOTHER | 1 | Dec 23, 2015 | clinicaltrials |
| NCT01840943 | A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | terminated | Phase 3 | 32 | Xian-Janssen Pharmaceutical Ltd.INDUSTRY | 1 | Dec 23, 2015 | clinicaltrials |
| NCT00067015 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | Phase 3 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | completed | Phase 2 / Phase 3 | 34 | Bristol-Myers SquibbINDUSTRY | 16 | Dec 7, 2015 | clinicaltrials |
| NCT01223027 | Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 564 | Novartis PharmaceuticalsINDUSTRY | 27 | Dec 7, 2015 | clinicaltrials |
| NCT00006392 | S0000 Selenium and Vitamin E in Preventing Prostate Cancer(SELECT) | completed | Phase 3 | 35,533 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00974818 | Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients | terminated | Phase 3 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | completed | Phase 3 | 949 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00241384 | Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer | completed | Phase 3 | 396 | Schiffler Cancer CenterOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00043082 | S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer | completed | Phase 3 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 26, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00685646 | Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases(ZAPCA) | completed | Phase 3 | 227 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00092521 | Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) | completed | Phase 3 | 5,759 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 25, 2015 | clinicaltrials |
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer(ICON6) | unknown | Phase 3 | 486 | Medical Research CouncilOTHER_GOV | 1 | Sep 23, 2015 | clinicaltrials |
| NCT00215631 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | terminated | Phase 3 | 100 | Erasmus Medical CenterOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01656161 | Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer | completed | Phase 3 | 120 | Debiopharm International SAINDUSTRY | 1 | Sep 15, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT01011751 | Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma | completed | Phase 3 | 311 | TakedaINDUSTRY | 1 | Jul 30, 2015 | clinicaltrials |
| NCT00420888 | ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma | completed | Phase 2 / Phase 3 | 526 | Active Biotech ABINDUSTRY | 5 | Jul 22, 2015 | clinicaltrials |
| NCT01546623 | A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy | completed | Phase 3 | 160 | TakedaINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00809458 | Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer | terminated | Phase 3 | 15 | New Mexico Cancer Research AllianceOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT00233727 | Screen and Treat for Cervical Cancer Prevention(SAT) | terminated | Phase 3 | 7,123 | Columbia UniversityOTHER | 1 | Jul 9, 2015 | clinicaltrials |
| NCT01744366 | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population(PANDA) | completed | Phase 3 | 285 | Ferring PharmaceuticalsINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jun 23, 2016source: clinicaltrials